{"url_path":"/sec/asst/10-q/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1920406/0001628280-26-034805-index.html","accession_number":"0001628280-26-034805","cik":"0001920406","ticker":"ASST","issuer_name":"Strive, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1920406/0001628280-26-034805-index.html","primary_entity_key":"0001920406","primary_entity_name":"Strive, Inc."},"word_count":605,"has_tables":true,"body_markdown":"asst-20260331\n00019204062026Q1false--12-310.050.0137694P1YP1Y110.050.050.050.05xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesasst:classasst:votexbrli:pureasst:bitcoiniso4217:USDasst:bitcoinasst:dayasst:segment00019204062026-01-012026-03-310001920406us-gaap:CommonClassAMember2026-01-012026-03-310001920406us-gaap:SeriesAPreferredStockMember2026-01-012026-03-310001920406us-gaap:CommonClassAMember2026-05-120001920406us-gaap:CommonClassBMember2026-05-1200019204062026-03-3100019204062025-12-310001920406us-gaap:SeriesAPreferredStockMember2026-03-310001920406us-gaap:SeriesAPreferredStockMember2025-12-310001920406us-gaap:CommonClassAMember2026-03-310001920406us-gaap:CommonClassAMember2025-12-310001920406us-gaap:CommonClassBMember2026-03-310001920406us-gaap:CommonClassBMember2025-12-310001920406us-gaap:InvestmentAdviceMember2026-01-012026-03-310001920406us-gaap:InvestmentAdviceMember2025-01-012025-03-310001920406asst:MedicalDeviceServicesMember2026-01-012026-03-310001920406asst:MedicalDeviceServicesMember2025-01-012025-03-310001920406us-gaap:ProductAndServiceOtherMember2026-01-012026-03-310001920406us-gaap:ProductAndServiceOtherMember2025-01-012025-03-3100019204062025-01-012025-03-310001920406us-gaap:PreferredStockMember2024-12-310001920406asst:PredecessorStockCommonClassAMemberus-gaap:CommonStockMember2024-12-310001920406asst:PredecessorStockCommonClassBMemberus-gaap:CommonStockMember2024-12-310001920406us-gaap:AdditionalPaidInCapitalMember2024-12-310001920406us-gaap:RetainedEarningsMember2024-12-3100019204062024-12-310001920406us-gaap:RetainedEarningsMember2025-01-012025-03-310001920406us-gaap:PreferredStockMember2025-03-310001920406asst:PredecessorStockCommonClassAMemberus-gaap:CommonStockMember2025-03-310001920406asst:PredecessorStockCommonClassBMemberus-gaap:CommonStockMember2025-03-310001920406us-gaap:AdditionalPaidInCapitalMember2025-03-310001920406us-gaap:RetainedEarningsMember2025-03-3100019204062025-03-310001920406asst:SuccessorClassACommonStockMemberus-gaap:CommonStockMember2025-12-310001920406asst:SuccessorClassBCommonStockMemberus-gaap:CommonStockMember2025-12-310001920406us-gaap:AdditionalPaidInCapitalMember2025-12-310001920406us-gaap:RetainedEarningsMember2025-12-310001920406asst:SuccessorClassACommonStockMemberus-gaap:CommonStockMember2026-01-012026-03-310001920406asst:SuccessorClassBCommonStockMemberus-gaap:CommonStockMember2026-01-012026-03-310001920406us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-310001920406us-gaap:RetainedEarningsMember2026-01-012026-03-310001920406asst:SuccessorClassACommonStockMemberus-gaap:CommonStockMember2026-03-310001920406asst:SuccessorClassBCommonStockMemberus-gaap:CommonStockMember2026-03-310001920406us-gaap:AdditionalPaidInCapitalMember2026-03-310001920406us-gaap:RetainedEarningsMember2026-03-3100019204062026-02-062026-02-060001920406asst:BitcoinMember2025-12-310001920406asst:BitcoinMember2026-01-012026-03-310001920406asst:BitcoinMember2026-03-310001920406asst:SemlerScientificInc.Member2026-01-162026-01-160001920406asst:SemlerScientificInc.Member2026-01-012026-03-310001920406asst:SemlerScientificInc.Member2026-01-160001920406asst:SemlerScientificInc.Memberasst:SemlerConvertibleNotesMemberus-gaap:ConvertibleDebtMember2026-01-160001920406asst:SemlerConvertibleNotesMemberus-gaap:ConvertibleDebtMember2026-01-222026-01-220001920406us-gaap:SeriesAPreferredStockMemberasst:SemlerConvertibleNotesMemberus-gaap:ConvertibleDebtMember2026-01-222026-01-220001920406us-gaap:SeriesAPreferredStockMemberasst:SemlerConvertibleNotesMemberus-gaap:ConvertibleDebtMember2026-01-220001920406asst:CoinbaseLoanMemberasst:SemlerScientificInc.Member2026-01-160001920406asst:CoinbaseLoanMemberasst:SemlerScientificInc.Member2026-01-012026-03-310001920406us-gaap:PreferredStockMember2025-12-310001920406us-gaap:PreferredStockMember2026-01-012026-03-310001920406us-gaap:PreferredStockMember2026-03-310001920406asst:SemlerConvertibleNotesMemberus-gaap:ConvertibleDebtMember2026-01-162026-01-160001920406asst:SemlerConvertibleNotesMemberus-gaap:ConvertibleDebtMember2026-01-012026-03-310001920406asst:SemlerConvertibleNotesMemberus-gaap:ConvertibleDebtMember2026-03-310001920406us-gaap:SubsequentEventMember2026-05-120001920406asst:SemlerConvertibleNotesMemberus-gaap:ConvertibleDebtMember2026-03-312026-03-310001920406us-gaap:FairValueInputsLevel1Member2026-03-310001920406us-gaap:FairValueInputsLevel1Member2025-12-310001920406asst:SemlerScientificInc.2014StockOptionAndIncentivePlanMember2026-01-162026-01-160001920406asst:SemlerScientificInc.2024StockOptionAndIncentivePlanMember2026-01-162026-01-160001920406us-gaap:EmployeeStockOptionMember2026-01-012026-03-310001920406asst:IncentiveStockOptionsMember2026-01-012026-03-310001920406asst:IncentiveStockOptionsMember2026-03-310001920406srt:MinimumMemberus-gaap:RestrictedStockMember2026-01-012026-03-310001920406srt:MinimumMemberus-gaap:RestrictedStockUnitsRSUMember2026-01-012026-03-310001920406srt:MaximumMemberus-gaap:RestrictedStockMember2026-01-012026-03-310001920406srt:MaximumMemberus-gaap:RestrictedStockUnitsRSUMember2026-01-012026-03-310001920406asst:A2022PlanMemberus-gaap:RestrictedStockMember2026-03-310001920406asst:A2026PlanMemberus-gaap:RestrictedStockMember2022-04-120001920406asst:A2026PlanMemberus-gaap:RestrictedStockMember2026-03-310001920406us-gaap:RestrictedStockUnitsRSUMember2026-01-012026-03-310001920406us-gaap:RestrictedStockUnitsRSUMember2025-01-012025-03-310001920406asst:PriorToSplitAdjustedBasisMemberus-gaap:RestrictedStockUnitsRSUMember2025-01-012025-03-3100019204062025-01-012025-12-310001920406asst:PIPEPreFundedWarrantsMemberus-gaap:CommonClassAMemberasst:PriorToSplitAdjustedBasisMemberasst:PIPETransactionsMember2025-05-260001920406asst:PIPEPreFundedWarrantsMemberus-gaap:CommonClassAMemberasst:PIPETransactionsMember2025-05-260001920406asst:PIPETraditionalWarrantsMemberus-gaap:CommonClassAMemberasst:PriorToSplitAdjustedBasisMemberasst:PIPETransactionsMember2025-05-260001920406asst:PIPETraditionalWarrantsMemberus-gaap:CommonClassAMemberasst:PIPETransactionsMember2025-05-260001920406asst:PIPETraditionalWarrantsMemberasst:PriorToSplitAdjustedBasisMember2025-12-310001920406asst:PIPEPreFundedWarrantsMemberasst:PriorToSplitAdjustedBasisMember2025-12-310001920406asst:PIPETraditionalWarrantsMemberasst:PriorToSplitAdjustedBasisMember2026-01-012026-03-310001920406asst:PIPEPreFundedWarrantsMemberasst:PriorToSplitAdjustedBasisMember2026-01-012026-03-310001920406asst:PIPETraditionalWarrantsMemberasst:PriorToSplitAdjustedBasisMember2026-03-310001920406asst:PIPEPreFundedWarrantsMemberasst:PriorToSplitAdjustedBasisMember2026-03-310001920406us-gaap:CommonClassAMemberasst:ASSTSalesAgreementMember2025-09-150001920406us-gaap:CommonClassAMemberasst:ASSTSalesAgreementMember2026-01-012026-03-310001920406us-gaap:CommonClassAMemberasst:ASSTSalesAgreementMember2026-03-310001920406us-gaap:CommonClassAMember2025-09-150001920406asst:PIPEPreFundedWarrantsMemberus-gaap:CommonClassAMember2026-03-310001920406asst:PIPETraditionalWarrantsMemberus-gaap:CommonClassAMember2026-03-310001920406us-gaap:SeriesAPreferredStockMemberasst:PublicStockOfferingMember2025-11-102025-11-100001920406us-gaap:SeriesAPreferredStockMemberasst:PublicStockOfferingMember2026-01-272026-01-270001920406us-gaap:SeriesAPreferredStockMember2025-11-102025-11-100001920406srt:MinimumMemberus-gaap:SeriesAPreferredStockMember2025-11-100001920406srt:MaximumMemberus-gaap:SeriesAPreferredStockMember2025-11-100001920406us-gaap:SeriesAPreferredStockMember2025-11-100001920406us-gaap:SeriesAPreferredStockMember2025-01-012025-12-310001920406us-gaap:SeriesAPreferredStockMemberasst:SATASalesAgreementMember2025-12-090001920406us-gaap:SeriesAPreferredStockMemberasst:SATASalesAgreementMember2026-01-012026-03-310001920406us-gaap:SeriesAPreferredStockMemberasst:SATASalesAgreementMember2026-03-310001920406us-gaap:InvestmentAdviceMemberasst:AssetManagementSegmentMember2026-01-012026-03-310001920406us-gaap:InvestmentAdviceMemberasst:MedicalDeviceSegmentMember2026-01-012026-03-310001920406us-gaap:InvestmentAdviceMemberus-gaap:CorporateAndOtherMember2026-01-012026-03-310001920406asst:MedicalDeviceServicesMemberasst:AssetManagementSegmentMember2026-01-012026-03-310001920406asst:MedicalDeviceServicesMemberasst:MedicalDeviceSegmentMember2026-01-012026-03-310001920406asst:MedicalDeviceServicesMemberus-gaap:CorporateAndOtherMember2026-01-012026-03-310001920406us-gaap:ProductAndServiceOtherMemberasst:AssetManagementSegmentMember2026-01-012026-03-310001920406us-gaap:ProductAndServiceOtherMemberasst:MedicalDeviceSegmentMember2026-01-012026-03-310001920406us-gaap:ProductAndServiceOtherMemberus-gaap:CorporateAndOtherMember2026-01-012026-03-310001920406asst:AssetManagementSegmentMember2026-01-012026-03-310001920406asst:MedicalDeviceSegmentMember2026-01-012026-03-310001920406us-gaap:CorporateAndOtherMember2026-01-012026-03-310001920406us-gaap:InvestmentAdviceMemberasst:AssetManagementSegmentMember2025-01-012025-03-310001920406us-gaap:InvestmentAdviceMemberasst:MedicalDeviceSegmentMember2025-01-012025-03-310001920406us-gaap:InvestmentAdviceMemberus-gaap:CorporateAndOtherMember2025-01-012025-03-310001920406asst:MedicalDeviceServicesMemberasst:AssetManagementSegmentMember2025-01-012025-03-310001920406asst:MedicalDeviceServicesMemberasst:MedicalDeviceSegmentMember2025-01-012025-03-310001920406asst:MedicalDeviceServicesMemberus-gaap:CorporateAndOtherMember2025-01-012025-03-310001920406us-gaap:ProductAndServiceOtherMemberasst:AssetManagementSegmentMember2025-01-012025-03-310001920406us-gaap:ProductAndServiceOtherMemberasst:MedicalDeviceSegmentMember2025-01-012025-03-310001920406us-gaap:ProductAndServiceOtherMemberus-gaap:CorporateAndOtherMember2025-01-012025-03-310001920406asst:AssetManagementSegmentMember2025-01-012025-03-310001920406asst:MedicalDeviceSegmentMember2025-01-012025-03-310001920406us-gaap:CorporateAndOtherMember2025-01-012025-03-310001920406asst:AssetManagementSegmentMember2026-03-310001920406asst:AssetManagementSegmentMember2025-12-310001920406asst:MedicalDeviceSegmentMember2026-03-310001920406asst:MedicalDeviceSegmentMember2025-12-310001920406us-gaap:CorporateAndOtherMember2026-03-310001920406us-gaap:CorporateAndOtherMember2025-12-310001920406asst:BitcoinMemberus-gaap:SubsequentEventMember2026-04-012026-05-120001920406asst:StrategyVariableRateSeriesAPerpetualStretchPreferredStockMemberus-gaap:SubsequentEventMember2026-05-120001920406asst:BitcoinMemberus-gaap:SubsequentEventMember2026-05-120001920406srt:ScenarioForecastMemberus-gaap:SeriesAPreferredStockMember2026-05-162026-05-160001920406us-gaap:CommonClassAMemberus-gaap:SubsequentEventMember2026-05-120001920406us-gaap:CommonClassBMemberus-gaap:SubsequentEventMember2026-05-120001920406us-gaap:SeriesAPreferredStockMemberus-gaap:SubsequentEventMember2026-05-120001920406us-gaap:SeriesAPreferredStockMemberus-gaap:SubsequentEventMember2026-05-122026-05-120001920406us-gaap:CommonClassAMemberasst:ASSTSalesAgreementMemberus-gaap:SubsequentEventMember2026-04-012026-05-120001920406us-gaap:CommonClassAMemberasst:ASSTSalesAgreementMemberus-gaap:SubsequentEventMember2026-05-120001920406us-gaap:SeriesAPreferredStockMemberasst:SATASalesAgreementMemberus-gaap:SubsequentEventMember2026-04-012026-05-120001920406us-gaap:SeriesAPreferredStockMemberasst:SATASalesAgreementMemberus-gaap:SubsequentEventMember2026-05-12\n\nUNITED STATES\n\nSECURITIES AND EXCHANGE COMMISSION\n\nWASHINGTON, D.C. 20549\n\n_____________________________________________\n\nFORM 10-Q\n\n_____________________________________________\n\n(Mark One)\n\nxQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\n\nFor the Quarterly Period Ended March 31, 2026\n\nOR\n\noTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\n\nFor the transition period from               to           \n\nCommission File Number 001-41612\n\n_________________________________________________________\n\nSTRIVE, INC.\n\n(Exact name of Registrant as Specified in Its Charter)\n\n_________________________________________________________\n\nNevada001-41612\n88-1293236\n\n(State or Other Jurisdiction\nof Incorporation)(Commission File Number)(IRS Employer\nIdentification No.)\n\n200 Crescent Ct., Suite 1400, Dallas, Texas 75201\n\n(Address of principal executive offices and zip code)\n\nRegistrant’s Telephone Number, Including Area Code: (855) 427-7360\n\n(Former Name or Former Address, if Changed Since Last Report)\n\nSecurities registered pursuant to Section 12(b) of the Act:\n\nTitle of Each ClassTrading SymbolName of Each Exchange on which Registered\n\nClass A common stock, $0.001 par value per shareASSTThe Nasdaq Stock Market LLC\n\nVariable Rate Series A Perpetual Preferred Stock, $0.001 par value per shareSATAThe Nasdaq Stock Market LLC\n\nIndicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐\n\nIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐\n\nIndicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.\n\nLarge accelerated filer☐Accelerated filer☐\n\nNon-accelerated filer☒Smaller reporting company☒\n\nEmerging growth company☒\n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\nIndicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒\n\nAs of May 12, 2026, the registrant had 63,211,995 and 9,870,636 shares of Class A common stock and Class B common stock outstanding, respectively.\n\nSTRIVE, INC.\n\nFORM 10-Q\n\nTABLE OF CONTENTS\n\nPage\n\n[PART I.](#i93a3cb13dd874aaa918e77295df3d3e2_10)\n\n[FINANCIAL INFORMATION](#i93a3cb13dd874aaa918e77295df3d3e2_10)\n\n[1](#i93a3cb13dd874aaa918e77295df3d3e2_10)\n\n[Item 1.](#i93a3cb13dd874aaa918e77295df3d3e2_13)\n\n[Consolidated Financial Statements](#i93a3cb13dd874aaa918e77295df3d3e2_13)\n\n[1](#i93a3cb13dd874aaa918e77295df3d3e2_13)\n\n[Consolidated Statements of Financial Condition as of March 31, 2026 (unaudited) and December 31, 2025 (audited)](#i93a3cb13dd874aaa918e77295df3d3e2_16)\n\n[1](#i93a3cb13dd874aaa918e77295df3d3e2_16)\n\n[Consolidated Statements of Operations (unaudited) for the Three Months Ended March 31, 2026 (Successor) and 2025 (Predecessor)](#i93a3cb13dd874aaa918e77295df3d3e2_19)\n\n[2](#i93a3cb13dd874aaa918e77295df3d3e2_19)\n\n[Consolidated Statements of Changes in Stockholders' Equity (unaudited) for the Three Months Ended March 31, 2026 (Successor) and 2025 (Predecessor)](#i93a3cb13dd874aaa918e77295df3d3e2_25)\n\n[3](#i93a3cb13dd874aaa918e77295df3d3e2_25)\n\n[Consolidated Statements of Cash Flows (unaudited) for the Three Months Ended March 31, 2026 (Successor) and 2025 (Predecessor)](#i93a3cb13dd874aaa918e77295df3d3e2_28)\n\n[4](#i93a3cb13dd874aaa918e77295df3d3e2_28)\n\n[Notes to Consolidated Financial Statements (unaudited)](#i93a3cb13dd874aaa918e77295df3d3e2_31)\n\n[6](#i93a3cb13dd874aaa918e77295df3d3e2_31)\n\n[Item 2.](#i93a3cb13dd874aaa918e77295df3d3e2_73)\n\n[Management’s Discussion and Analysis of Financial Condition and Results of Operations](#i93a3cb13dd874aaa918e77295df3d3e2_73)\n\n[21](#i93a3cb13dd874aaa918e77295df3d3e2_73)\n\n[Item 3.](#i93a3cb13dd874aaa918e77295df3d3e2_106)\n\n[Quantitative and Qualitative Disclosures About Market Risk](#i93a3cb13dd874aaa918e77295df3d3e2_106)\n\n[29](#i93a3cb13dd874aaa918e77295df3d3e2_106)\n\n[Item 4.](#i93a3cb13dd874aaa918e77295df3d3e2_109)\n\n[Controls and Procedures](#i93a3cb13dd874aaa918e77295df3d3e2_109)\n\n[29](#i93a3cb13dd874aaa918e77295df3d3e2_109)\n\n[PART II.](#i93a3cb13dd874aaa918e77295df3d3e2_112)\n\n[OTHER INFORMATION](#i93a3cb13dd874aaa918e77295df3d3e2_112)\n\n[30](#i93a3cb13dd874aaa918e77295df3d3e2_112)\n\n[Item 1.](#i93a3cb13dd874aaa918e77295df3d3e2_115)\n\n[Legal Proceedings](#i93a3cb13dd874aaa918e77295df3d3e2_115)\n\n[30](#i93a3cb13dd874aaa918e77295df3d3e2_115)\n\n[Item 1A.](#i93a3cb13dd874aaa918e77295df3d3e2_118)\n\n[Risk Factors](#i93a3cb13dd874aaa918e77295df3d3e2_118)\n\n[30](#i93a3cb13dd874aaa918e77295df3d3e2_118)\n\n[Item 2.](#i93a3cb13dd874aaa918e77295df3d3e2_121)\n\n[Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities](#i93a3cb13dd874aaa918e77295df3d3e2_121)\n\n[30](#i93a3cb13dd874aaa918e77295df3d3e2_121)"}